Literature DB >> 4752412

Hyperaggregation effect in idiopathic thrombocytopenia and multiple transfused patients.

N Wagner, T J Degnan.   

Abstract

A new technique for detecting platelet antibodies was investigated. The serum from patients having platelet antibodies was added to normal group O compatible pooled platelet-rich plasma. Platelet aggregation induced by adrenaline and adenosine diphosphate (ADP) was significantly increased as compared to the identical platelet-rich plasma without serum. The platelet-rich plasma with serum added did not aggregate spontaneously. When an alpha-adrenergic blocking agent (tolazoline) was added, the primary wave of aggregation induced by adrenaline was equally reversed with platelet-rich plasma, with or without serum. Although platelet antibodies by themselves did not agglutinate platelets in our test system, it is probable that platelet antibodies interact with platelets and potentiate their ability to aggregate. It is suggested that the platelet aggregometer is a useful tool for the detection of platelet antibodies in vitro.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4752412      PMCID: PMC477854          DOI: 10.1136/jcp.26.9.697

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA.

Authors:  H I HOROWITZ; H I RAPPAPORT; R C YOUNG; M M FUJIMOTO
Journal:  Transfusion       Date:  1965 Jul-Aug       Impact factor: 3.157

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Thrombocytopenia with a circulating platelet agglutinin, platelet agglutinin, platelet lysin and clot retraction inhibitor.

Authors:  M B ZUCKER; A B LEY; J BORRELLI; K MAYER; J FIRMAT
Journal:  Blood       Date:  1959-02       Impact factor: 22.113

4.  Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura.

Authors:  W J HARRINGTON; C C SPRAGUE; V MINNICH; C V MOORE; R C AULVIN; R DUBACH
Journal:  Ann Intern Med       Date:  1953-03       Impact factor: 25.391

5.  The cause of thrombocytopenia in sedormid purpura.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1949-12-19       Impact factor: 6.124

6.  Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura.

Authors:  R Clancy; E Jenkins; B Firkin
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

7.  In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus.

Authors:  S Karpatkin; G W Siskind
Journal:  Blood       Date:  1969-06       Impact factor: 22.113

8.  The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.

Authors:  D Deykin; L J Hellerstein
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.